Work for Oncolytics Biotech Inc.?

Claim Your Profile

Oncolytics Biotech Inc. Logo Image

Oncolytics Biotech Inc.

Oncolytics Biotech Inc. Banner Image

About Oncolytics Biotech Inc.

11-50 Employees
Based in Calgary, Alberta

Oncolytics Biotech Inc. is developing pelareorep, a safe and well-tolerated intravenously delivered immuno-oncolytic virus (IOV) that targets cancer through a unique mechanism of action with two components, selective tumor lysis and activation of the innate and adaptive immune systems, creating an inflamed phenotype to treat a variety of solid tumors and hematological malignancies.

Ticker:
ONC
Exchange:
TSX (See More TSX Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol